Meghan Gutierrez, CEO, Lymphoma Research Foundation & Jennifer Branstetter, Executive Director, North America Corporate Affairs & Patient Advocacy Lead, BeOne Medicines - Smarter Cancer Care: The Promise of Patient-Centric AI

Send us Fan Mail Meghan Gutierrez is the Chief Executive Officer of the Lymphoma Research Foundation ( https://lymphoma.org/ ), the nation’s largest nonprofit organization devoted to funding lymphoma research and education, advancing both the study of new cancer therapies and improved patient care. An expert in government relations and health care policy, Meghan has pursued an array of public policy issues during her career, ranging from mental health parity and rare disease awareness to medical technology and the treatment of chronic disease. Following her work as a Congressional staff member for Dr. Greg Ganske, one of the U.S. House of Representatives’ foremost leaders on health care policy, she served as a health policy and communications advisor for several national nonprofit and educational institutions, including Columbia University and the Partnership for a Drug-Free America. Meghan joined the Lymphoma Research Foundation in 2008 as its chief program, policy and communications officer. She was a driving force behind programs such as the country’s only Adolescent and Young Adult Lymphoma Initiative and development of the first mobile app for people with lymphoma. She became Chief Executive Officer in 2014. In this role Meghan represents the Foundation before several audiences, including the U.S. Congress, Department of Defense, Food and Drug Administration and National Institutes of Health. She has written and lectured extensively about the needs of lymphoma patients and served on committees and panels of the American Society of Clinical Oncology, American Society of Hematology, Institute of Medicine, and National Cancer Institute, among others. Jennifer Branstetter is Executive Director, North America Corporate Affairs & Patient Advocacy Lead at BeOne Medicines USA ( https://beonemedicines.com/ ), a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. Jennifer has a demonstrated 25+ year history of working with Fortune 500 pharmaceutical companies, in government, and with nonprofits and the media, and has been a strategist for multi-faceted state and federal public affairs and patient advocacy campaigns. Previously, Jennifer was a Senior Director, Corporate Affairs (North America) at BeOne and also held positions at Cullari Communications Global, Branstetter Consulting, as Director of Policy and Planning in the Commonwealth of PA, Governor's Office, for Governor Tom Corbett, as Director of Education and Outreach for Pennsylvania Office of Attorney General, as Communications Manager for the Pennsylvania Bar Association, and as Deputy Press Secretary in the Pennsylvania Office of the Lieutenant Governor during the administration of Governor Tom Ridge. #MeghanGutierrez #JenniferBranstetter #BeOneMedicines #LymphomaResearchFoundation #PatientAdvocacy #PatientCentricAI #PatientNavigation #ClinicalTrialEligibility #FinancialToxicityDetection #PatientDistress #AutomatedInsuranceNavigation #EquityRadar #RegulatoryAdvocacy #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast Support the show